European Liquid Biopsy Society (ELBS) shared on LinkedIn:
“What Can Liquid Biopsy Reveal About the Immune Landscape in Metastatic Breast Cancer?
A new publication by Keerthi Kurma, Thomas Bardol, Caroline Mollevi, Zahra Eslami-S and colleagues, including Catherine Alix-Panabières, explores the systemic immune and protein profiles associated with circulating tumor cell (CTC) burden and clinical outcomes in metastatic breast cancer.
Using an integrated liquid biopsy approach, the study identifies profound immune alterations and an inflammatory, pro-angiogenic protein signature. Notably, IL-8 and NOS3 emerged as independent predictors of progression-free survival.
These findings highlight the potential of combining cellular and proteomic liquid biopsy analyses to better understand disease progression and identify clinically relevant biomarkers.
Curious to learn more? Read the publication.”
Catherine Alix-Panabières, Visiting Professor at University of Hamburg, added:
“Amazing data on circulating immune cells (CICs) in liquid biopsy, complementing the analysis of Circulating Tumor Cells (CTCs) and plasma proteomics.
Let’s not forget that the immune system plays a crucial role in maintaining the delicate balance between cancer progression and disease stability (no progression)!
Happy reading!”
Title: Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer
Authors: Keerthi Kurma, Thomas Bardol, Caroline Mollevi, Zahra Eslami-S, Françoise Garima, Marie Alexandre, Angélique Bobrie, Gerald Lossaint, Blandine Massemin, Véronique D’Hondt, Séverine Guiu, Laure Cayrefourcq, William Jacot, Catherine Alix-Panabières
Key Takeaways
- Researchers used liquid biopsy to examine circulating tumor cells, immune cells and plasma proteins in patients with metastatic breast cancer.
- The results showed changes in immune activity, including lower T-cell levels and signs of T-cell exhaustion.
- The study also found increased levels of inflammatory and pro-angiogenic proteins linked to disease progression.
- IL-8 and NOS3 were identified as independent markers associated with progression-free survival.
- The findings suggest that combining different liquid biopsy approaches could help track disease progression and identify potential biomarkers in metastatic breast cancer.
You may also be interested in: